Eliksa Therapeutics launched with University of Utah’s commercial and clinical-stage regenerative medicine technology Founding investors include Militia Hill Ventures and University of Utah See more here
Read More
Category
Eliksa Therapeutics
© 2024 BioAdvance. All Rights Reserved. | Privacy Policy | Site by Loudmark
101 West Elm Street, Suite 330, Conshohocken, PA 19428 | (610) 230-0544